Can AAV continue to deliver the promise of gene therapy?
September 13, 2023
In this episode, Charlotte Barker, Editor, BioInsights, will be discussing the future of AAV-based gene therapy manufacturing with Elie Hanania, VP of Process Development Viral Vector Technologies at Avid Bioservices, and Ratish Krishnan, Senior Strategy Consultant at Merck Life Sciences.
Does AAV still reign supreme for advanced therapies?
What has AAV evolved over the past 5 years and how do you see the future?
As use of AAV continues to grow, what challenges stand in its way?
What promising innovations in AAV production do you see emerging over the next 5 years?
How can we streamline AAV manufacturing for common disease indications?